44 publications
| Name | Date | Type | Actions |
|---|---|---|---|
Vétoquinol continues to launch reference products Lure (France), December 16, 2013 – In line with its strategy of developing products targeting fast-growing markets, the Vétoquinol Group expands its Flexadin® range world-wide and launches Zylkène® in the United States. |
Public releases | ||
Monthly information regarding the total number of voting rights and shares making of the share capital - November 2013 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
Voting rights | ||
Monthly information regarding the total number of voting rights and shares making of the share capital - October 2013 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
Voting rights | ||
2013 3rd quarter sales show organic growth Vétoquinol generated sales of €74.0 million in the 3rd quarter of 2013, a drop of 0.1% based on reported data, and a 4.4% increase at constant exchange rates. |
Public releases | ||
Monthly information regarding the total number of voting rights and shares making of the share capital - September 2013 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
Voting rights | ||
Monthly information regarding the total number of voting rights and shares making of the share capital - august 2013 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
Voting rights | ||
The reference products demonstrate solid growth Lure (France), August 29, 2013 – At its meeting on August 27, 2013, the Vétoquinol S.A. Board of Directors reviewed the Group’s results, and approved the financial statements for the first six months of 2013. |
Public releases | ||
Monthly information regarding the total number of voting rights and shares making of the share capital - july 2013 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
Voting rights | ||
Q2 2013 sales Vétoquinol posted Q2 2013 sales of €70 million, up 0.3% on reported figures and up 1.4% like for like. |
Public releases | ||
Monthly information regarding the total number of voting rights and shares making of the share capital - june 2013 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
Voting rights |